Bo Su

6.3k total citations · 2 hit papers
56 papers, 5.2k citations indexed

About

Bo Su is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Su has authored 56 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Physiology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Su's work include Alzheimer's disease research and treatments (17 papers), Mitochondrial Function and Pathology (16 papers) and Lung Cancer Treatments and Mutations (7 papers). Bo Su is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Mitochondrial Function and Pathology (16 papers) and Lung Cancer Treatments and Mutations (7 papers). Bo Su collaborates with scholars based in China, United States and Japan. Bo Su's co-authors include Xinglong Wang, Xiongwei Zhu, George Perry, Mark A. Smith, Hyoung‐gon Lee, Hisashi Fujioka, Gemma Casadesús, Xiang Li, Paula I. Moreira and Sandra L. Siedlak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Bo Su

54 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

2009 1.0k citations Xinglong Wang, Bo Su et al. Journal of Neuroscience profile →
Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

2008 714 citations Xinglong Wang, Bo Su et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Su China	26	3.3k	2.6k	920	643	523	56	5.2k
Shirley ShiDu Yan United States	41	2.9k 0.9×	2.8k 1.1×	716 0.8×	759 1.2×	441 0.8×	72	5.3k
Peizhong Mao United States	24	2.4k 0.7×	1.9k 0.7×	1.0k 1.1×	409 0.6×	368 0.7×	35	4.0k
Heng Du United States	31	2.7k 0.8×	2.3k 0.9×	756 0.8×	591 0.9×	390 0.7×	73	4.4k
Joanna B. Strosznajder Poland	36	2.4k 0.7×	1.9k 0.7×	1.0k 1.1×	566 0.9×	282 0.5×	165	4.8k
Rodrigo A. Quintanilla Chile	36	2.4k 0.7×	1.8k 0.7×	1.0k 1.1×	484 0.8×	277 0.5×	80	4.2k
Wenzhang Wang China	26	2.2k 0.7×	1.5k 0.6×	502 0.5×	404 0.6×	461 0.9×	49	4.1k
Sic L. Chan United States	44	3.6k 1.1×	2.7k 1.0×	2.1k 2.3×	541 0.8×	381 0.7×	83	8.1k
Ángeles Almeida Spain	47	4.5k 1.4×	2.1k 0.8×	1.7k 1.8×	267 0.4×	577 1.1×	112	8.0k
Sandra Moreno Italy	35	1.9k 0.6×	1.0k 0.4×	845 0.9×	362 0.6×	299 0.6×	80	3.6k
Maria Mańczak United States	40	5.5k 1.7×	4.9k 1.9×	1.8k 1.9×	1.1k 1.8×	963 1.8×	85	8.9k

Countries citing papers authored by Bo Su

Since Specialization

Citations

This map shows the geographic impact of Bo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Su more than expected).

Fields of papers citing papers by Bo Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Su. The network helps show where Bo Su may publish in the future.

Co-authorship network of co-authors of Bo Su

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Su. A scholar is included among the top collaborators of Bo Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Su. Bo Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Hui, et al.. (2024). miR-143-3p modulates depressive-like behaviors via Lasp1 in the mouse ventral hippocampus. Communications Biology. 7(1). 944–944. 2 indexed citations

Ding, Xi, et al.. (2024). Disulfiram/copper complex improves the effectiveness of the WEE1 inhibitor Adavosertib in p53 deficient non-small cell lung cancer via ferroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167455–167455. 8 indexed citations

You, Pan, et al.. (2022). REEP1 Preserves Motor Function in SOD1G93A Mice by Improving Mitochondrial Function via Interaction with NDUFA4. Neuroscience Bulletin. 39(6). 929–946. 8 indexed citations

Wang, Dongdong, Yang Li, Hongxia Chu, et al.. (2017). Pre-synaptic TrkB in basolateral amygdala neurons mediates BDNF signaling transmission in memory extinction. Cell Death and Disease. 8(7). e2959–e2959. 12 indexed citations

Hou, Likun, Shengxiang Ren, Bo Su, et al.. (2016). High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma. Journal of Thoracic Disease. 8(6). 1103–1111. 12 indexed citations

Liu, Di, Wen Xu, Zhiwei Zhang, et al.. (2015). RB1 Polymorphism Contributes to the Efficacy of Platinum-Taxanes in Advanced Squamous Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention. 16(2). 775–781. 3 indexed citations

Zheng, Hui, et al.. (2015). WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients. Scientific Reports. 5(1). 11114–11114. 13 indexed citations

Wu, Chunyan, et al.. (2014). High Feasibility of Liquid-Based Cytological Samples for Detection of EGFR Mutations in Chinese Patients with NSCLC. Asian Pacific Journal of Cancer Prevention. 15(18). 7885–7889. 15 indexed citations

Zeng, Xi, Juanjuan Xiang, Minghua Wu, et al.. (2012). Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma. PLoS ONE. 7(10). e46367–e46367. 125 indexed citations

10.

Li, Wei, Xiaoling Li, Wenqian Wang, et al.. (2011). NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma. Carcinogenesis. 32(9). 1305–1314. 39 indexed citations

11.

Sheng, Baiyang, Xinglong Wang, Bo Su, et al.. (2011). Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. Journal of Neurochemistry. 120(3). 419–429. 448 indexed citations

12.

Su, Bo, Xinglong Wang, David Bonda, et al.. (2010). Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?. Molecular Neurobiology. 41(2-3). 87–96. 68 indexed citations

13.

Su, Bo, Xinglong Wang, Hyoung‐gon Lee, et al.. (2009). Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neuroscience Letters. 468(3). 267–271. 147 indexed citations

14.

Su, Bo, Xinglong Wang, Ling Zheng, et al.. (2009). Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(1). 135–142. 230 indexed citations

15.

Su, Bo, Bo Xiang, Li Wang, et al.. (2009). Profiling and comparing transcription factors activated in non‐metastatic and metastatic nasopharyngeal carcinoma cells. Journal of Cellular Biochemistry. 109(1). 173–183. 11 indexed citations

16.

Su, Bo, Haihua Liu, Xinglong Wang, et al.. (2009). Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Molecular Neurodegeneration. 4(1). 32–32. 37 indexed citations

17.

Wang, Xinglong, Bo Su, Hyoung‐gon Lee, et al.. (2009). Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease. Journal of Neuroscience. 29(28). 9090–9103. 1005 indexed citations breakdown →

18.

Zhu, Xiaofeng, Bo Su, Xinglong Wang, Mark A. Smith, & George Perry. (2007). Causes of oxidative stress in Alzheimer disease. Cellular and Molecular Life Sciences. 64(17). 2202–2210. 300 indexed citations

19.

Wang, Xinglong, Bo Su, George Perry, Mark A. Smith, & Xiongwei Zhu. (2007). Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease. Free Radical Biology and Medicine. 43(12). 1569–1573. 88 indexed citations

20.

Xu, Yan, et al.. (2006). Expression of Collagen IV, Fibronectin, Laminin in Non-small Cell Lung Cancer and Its Correlation with Chemosensitivities and Apoptosis. The Chinese-German Journal of Clinical Oncology. 5(1). 58–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact